DXCM 60.69 (-1.53%)
US2521311074Medical Diagnostics & ResearchDiagnostics & Research

DexCom (DXCM) Stock Highlights

60.69 | -1.53%
2025-04-08 21:43:57
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem.

Statistics

Range Today
59.97 63.89
Volume Today 5.25M
Range 1 Year
57.52 141.99
Volume 1 Year 1.03B
Range 3 Year
57.52 142
Volume 3 Year 2.62B
Range 10 Year
10.65 573.01
Volume 10 Year 10.34B

Highlights

Market Capitalization 23.46B (large)
Floating Shares 387.84M
Current Price 60.69
Price To Earnings 41.99
Price To Revenue 5.99
Price To Book 11.12
Earnings Per Share 1.42
Payout Ratio 0%

Performance

Latest -1.53%
1 Month -18.8%
3 Months -23.27%
6 Months -11.86%
1 Year -56.5%
3 Years -52.4%
5 Years -4.95%
10 Years +285.09%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.